We investigated the effectiveness and safety of mirabegron oral treatment in a group of patients with Parkinson's disease (PD) and overactive bladder (OAB), refractory to antimuscarinics.

Feasibility of mirabegron in the treatment of overactive bladder in patients affected by Parkinson's disease: A pilot study / Gubbiotti, Marilena; Conte, Antonella; Di Stasi, Savino M; Tambasco, Nicola; Giannantoni, Antonella. - In: THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS. - ISSN 1756-2856. - 12:(2019), pp. 1-9. [10.1177/1756286419843458]

Feasibility of mirabegron in the treatment of overactive bladder in patients affected by Parkinson's disease: A pilot study

Conte, Antonella;
2019

Abstract

We investigated the effectiveness and safety of mirabegron oral treatment in a group of patients with Parkinson's disease (PD) and overactive bladder (OAB), refractory to antimuscarinics.
2019
Parkinson’s disease; mirabegron; overactive bladder
01 Pubblicazione su rivista::01a Articolo in rivista
Feasibility of mirabegron in the treatment of overactive bladder in patients affected by Parkinson's disease: A pilot study / Gubbiotti, Marilena; Conte, Antonella; Di Stasi, Savino M; Tambasco, Nicola; Giannantoni, Antonella. - In: THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS. - ISSN 1756-2856. - 12:(2019), pp. 1-9. [10.1177/1756286419843458]
File allegati a questo prodotto
File Dimensione Formato  
Gubbiotti_Mirabregon_2019.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 451.35 kB
Formato Adobe PDF
451.35 kB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1278872
Citazioni
  • ???jsp.display-item.citation.pmc??? 4
  • Scopus 13
  • ???jsp.display-item.citation.isi??? 12
social impact